Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke.
IMPORTANCE: Preclinical stroke research has had a remarkably low translational success rate, and the clinical need for novel neuroprotective therapeutics has gone largely unmet, especially in light of the severe underuse of thrombolysis in acute ischemic stroke. OBJECTIVE: In this review, we aim to...
Հիմնական հեղինակներ: | Neuhaus, A, Rabie, T, Sutherland, B, Papadakis, M, Hadley, G, Cai, R, Buchan, A |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
American Medical Association
2014
|
Նմանատիպ նյութեր
-
Neuroprotection in stroke: the importance of collaboration and reproducibility.
: Neuhaus, A, և այլն
Հրապարակվել է: (2017) -
Extended preclinical investigation of lactate for neuroprotection after ischemic stroke
: Lara Buscemi, և այլն
Հրապարակվել է: (2020-02-01) -
Memantine as a neuroprotective agent in ischemic stroke: Preclinical and clinical analysis
: Diego Pichardo-Rojas, և այլն
Հրապարակվել է: (2023-01-01) -
Rapamycin in ischemic stroke: Old drug, new tricks?
: Hadley, G, և այլն
Հրապարակվել է: (2018) -
Cortistatin exerts an immunomodulatory and neuroprotective role in a preclinical model of ischemic stroke
: J. Castillo-González, և այլն
Հրապարակվել է: (2024-12-01)